Spyre Therapeutics, Inc. Common Stock (SYRE) is a publicly traded Healthcare sector company. As of July 13, 2026, SYRE trades at $93.59 with a market cap of $8.49B and a P/E ratio of 0.00. SYRE moved -3.83% today. Year to date, SYRE is +206.59%; over the trailing twelve months it is +512.41%. Its 52-week range spans $10.91 to $102.06. Analyst consensus is strong buy with an average price target of $104.38. Rallies surfaces SYRE's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks politician and congressional stock disclosures for SYRE, including purchases, sales, transaction dates, owners, and reported trade amounts when available.
| Metric | Value |
|---|---|
| Price | $93.59 |
| Market Cap | $8.49B |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $102.06 |
| 52-Week Low | $10.91 |
| Volume | 248.56K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $-155.20M |
| Gross Margin | 0.00% |
15 analysts cover SYRE: 0 strong buy, 15 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $104.38.